Satsuma Pharmaceuticals, Inc. Accrued Liabilities, Current
Satsuma Pharmaceuticals, Inc. had Accrued Liabilities, Current of $4.84 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-05-11
- 2023-03-31: Accrued Liabilities, Current $4.84M.
- 2022-12-31: Accrued Liabilities, Current $6.07M.
- 2022-09-30: Accrued Liabilities, Current $4.55M.
- 2022-06-30: Accrued Liabilities, Current $6.13M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2023-03-31 | $4.84M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.07M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $4.55M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $6.13M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $4.07M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $5.94M 10-K · filed 2023-03-28 |
| 2021-09-30 | $3.40M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.41M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $2.21M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.67M 10-K · filed 2022-03-15 |
| 2020-09-30 | $2.43M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $2.12M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $1.81M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $1.71M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.69M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $1.50M 10-K · filed 2020-03-10 |